PURMX Therapeutics
Latest round
- Series A
Last raised
- May 2024
Total raised
- $9M
Investors
- 7
About PURMX Therapeutics
Founded in 2021 and based in Hiroshima, Japan, PURMX Therapeutics, Inc. operates as a research and development company that develops nucleic acid drugs containing microRNA as an active ingredient. The company develops treatments for malignant thoracic tumors. In May 2022, PURMX Therapeutics, Inc. The company operates as a drug developer, which focuses on replacing lacking small RNAs (microRNA) in cells. The company now has one pipeline undergoing, MIRX002, a nucleic acid medicine for malignant pleural mesothelioma.
Who invested in PURMX Therapeutics
7 investors across 3 rounds
See all investors in PURMX Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PURMX Therapeutics
Who invested in PURMX Therapeutics?
PURMX Therapeutics has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PURMX Therapeutics raised?
PURMX Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did PURMX Therapeutics last raise money?
PURMX Therapeutics's most recent round on record is a Series A, in May 2024.
What does PURMX Therapeutics do?
Founded in 2021 and based in Hiroshima, Japan, PURMX Therapeutics, Inc.
Where is PURMX Therapeutics headquartered?
PURMX Therapeutics is headquartered in Hiroshima-shi, Japan.
Which VCs invest in companies like PURMX Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at PURMX Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like PURMX Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.